The recent surge in investments into boutique pharmaceutical companies, particularly those focusing on novel therapies and challenging drug development programs, has fueled what some are calling "High Investor Pharma." https://jaysontppm537536.targetblogs.com/40477522/high-roller-pharma-hazardous-investment